✦ LIBER ✦

The role of recombinant interferon alfa-2a in the therapy of cutaneous t-cell lymphomas

✍ Scribed by Paul A. Bunn Jr; Daniel C. Ihde; Kenneth A. Foon

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 725 KB
Volume: 57
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19860415)57:8+<1689::aid-cncr2820571311>3.0.co;2-m

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant interferon alfa-2a, an activ

Recombinant interferon alfa-2a, an active agent in advanced cutaneous t-cell lymphomas

✍ P. A. Bunn Jr.; D. C. Ihde; K. A. Foon 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 452 KB

The cutaneous T-cell lymphomas including mycosis fungoides and the Sézary syndrome, are indolent lymphomas with early systemic dissemination. Like the indolent B-cell lymphomas, they cannot be cured by currently available systemic chemotherapy so new systemic therapies need to be developed. A study

Results of a Phase II trial of oral bexa

Results of a Phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma

✍ David J. Straus; Madeleine Duvic; Timothy Kuzel; Steven Horwitz; Marie-France De 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

## Abstract ## BACKGROUND. Bexarotene is one of the most active single agents for the treatment of recurring or refractory cutaneous T‐cell lymphoma (CTCL). Interferon alfa has also been used for many years as an effective treatment for this disease. The results in recent case reports of the combi

Role of extracorporeal photopheresis in

Role of extracorporeal photopheresis in the treatment of cutaneous t-cell lymphoma, autoimmune disease, and allograft rejection

✍ Alain H. Rook; Jonathan T. Wolfe 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB

Photopheresis is a pheresis-based therapy that is currently available at approximately 70 medical centers worldwide. Recent evidence indicates that extracorporeal photopheresis can significantly prolong life, as well as induce a 6&750/0 response rate among individuals with advanced cutaneous T-cell

Treatment of carcinoma of the esophagus

Treatment of carcinoma of the esophagus with 5-fluorouracil and recombinant alfa-2a-interferon

✍ Scott Wadler; Stanley Fell; Hilda Haynes; Henry J. Katz; Alla Rozenblit; Ronald 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 2 views

Phase II trial of recombinant interferon

Phase II trial of recombinant interferon alfa-2 in the treatment of primary systemic amyloidosis

✍ Dr. Morie A. Gertz; Robert A. Kyle 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 2 views

The role of radiation therapy in the man

The role of radiation therapy in the management of the non-Hodgkin's lymphomas

✍ Richard T. Hoppe 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 690 KB

Radiation therapy has a broad range of applications in the management of patients with non-Hodgkin's lymphoma. It has curative potential for patients with Stage I to I1 low-grade lymphoma (small lymphocytic, follicular small cleaved, and follicular mixed) and has substantial palliative efficacy in p